Cancer Institute of New Jersey (CINJ), Gastrointestinal Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Gastrointestinal Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

gemcitabine Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

  • 2372 Citations
  • 21 h-Index
  • 45 Article
  • 3 Chapter
  • 3 Review article
  • 1 Editorial

Conditional survival analysis of metastatic colorectal cancer patients living ≥24 months: A single institutional study

Ali, N. D., Donohue, K., Zandieh, S., Chen, C., Moore, D., Poplin, E., Shah, M. M., Nosher, J., Gui, B., Jabbour, S., Spencer, K. & Carpizo, D., Jun 1 2019, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 42, 6, p. 512-518 7 p.

Research output: Contribution to journalArticle

Survival Analysis
Colorectal Neoplasms
Survival
Neoplasms
Databases

Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis

Bajpai, M., Seril, D., Van Gurp, J., Geng, X., Alvarez, J., Minacapelli, C. D., Gorin, S., Das, K. K., Poplin, E., Cheng, J., Amenta, P. S. & Das, K. M., Mar 15 2019, In : Digestive Diseases and Sciences. 64, 3, p. 740-750 11 p.

Research output: Contribution to journalArticle

Mesalamine
Neoplasm Genes
Ulcerative Colitis
Mucous Membrane
Gene Expression

MiR-206 as a biomarker for response to mesalamine treatment in ulcerative colitis

Minacapelli, C. D., Bajpai, M., Geng, X., Van Gurp, J., Poplin, E., Amenta, P. S., Brant, S. & Das, K. M., Jan 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 78-84 7 p.

Research output: Contribution to journalArticle

Mesalamine
Ulcerative Colitis
Biomarkers
Adenosine A3 Receptors
HT29 Cells